Contact Trevor

Speaking Engagements

  

Over the last half-decade, we have witnessed game-changing developments within the cannabinoid field, driving it into a new era of rigorous research, promising clinical trials and multimillion-dollar deals.

06-08 September 2022
  

The approval of COVID-19 vaccines was the breakthrough for mRNA-based technology, and it opened so many opportunities for mRNA-based vaccines and therapeutics. CHI’s 2nd Annual mRNA-Based Therapies conference will explore the technical challenges facing the manufacture and purification, formulation, development, scale-up, and supply of next-generat

16-17 August 2023